Published in Am J Clin Pathol on June 01, 2007
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology (2009) 4.82
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci (2014) 2.03
Advances in pediatric nonalcoholic fatty liver disease. Hepatology (2009) 2.03
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology (2008) 1.29
TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase. Development (2009) 1.28
Adipocytokines and liver disease. J Gastroenterol (2008) 1.25
Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol (2012) 1.21
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr (2009) 1.12
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol (2014) 1.04
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol (2014) 1.02
Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol (2014) 0.92
The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. J Clin Exp Hepatol (2015) 0.89
Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males. J Gastroenterol (2011) 0.89
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clin Lipidol (2011) 0.89
CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol (2013) 0.87
Serum levels of TGF-β1 and MCP-1 as biomarkers for progressive coal workers' pneumoconiosis in retired coal workers: a three-year follow-up study. Ind Health (2014) 0.86
Fatty liver disease in children: eat now pay later. Hepatol Int (2010) 0.85
Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines. Medicine (Baltimore) (2016) 0.85
Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS One (2013) 0.84
Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. Hepat Med (2010) 0.83
Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study. Saf Health Work (2010) 0.83
5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. Mol Pharmacol (2012) 0.79
Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. World J Hepatol (2016) 0.78
Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World J Gastroenterol (2015) 0.78
Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life. Biomed Res Int (2015) 0.78
Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices. Fibrogenesis Tissue Repair (2014) 0.76
Chronic stress induces steatohepatitis while decreases visceral fat mass in mice. BMC Gastroenterol (2014) 0.76
Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. Korean J Pediatr (2013) 0.76
Gut Microbiota of Nonalcoholic Fatty Liver Disease. Dig Dis Sci (2016) 0.76
Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse model. Int J Mol Sci (2015) 0.75
Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab (2016) 0.75
Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis. Clin Mol Hepatol (2013) 0.75
Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol (2017) 0.75
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2010) 2.95
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology (2015) 2.81
NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology (2006) 2.06
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology (2008) 2.04
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology (2008) 2.02
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr (2012) 1.91
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol (2011) 1.73
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology (2008) 1.71
Preemptive liver transplantation in a child with familial hypercholesterolemia. Pediatr Transplant (2010) 1.71
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology (2010) 1.70
Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis (2002) 1.68
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology (2008) 1.66
Genotype-phenotype correlation in Italian children with Wilson's disease. J Hepatol (2008) 1.63
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest (2010) 1.60
Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr (2011) 1.59
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care (2007) 1.58
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol (2011) 1.52
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology (2008) 1.52
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. Diabetes Care (2007) 1.48
Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother (2011) 1.45
Human hepatic stellate cells are liver-resident antigen-presenting cells. Hepatology (2011) 1.42
Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr (2015) 1.42
Molecular genetics of NASH: the role of polymorphisms. J Hepatol (2007) 1.38
Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr (2013) 1.32
Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol (2012) 1.19
Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr (2010) 1.18
Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr (2009) 1.14
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther (2008) 1.11
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol (2011) 1.09
Retinoids counteract insulin resistance and liver steatosis: what's the potential mechanism? Hepatology (2013) 1.06
Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med (2011) 1.05
A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol (2010) 1.05
Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic (2007) 1.04
Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr (2004) 1.04
Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis (2009) 1.03
Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol (2006) 1.03
Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol (2009) 1.01
Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol (2006) 1.01
Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med (2005) 1.00
Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol (2009) 1.00
Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology (2008) 1.00
Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev (2011) 1.00
Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology (2010) 0.99
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int (2012) 0.96
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol (2009) 0.96
Dual role of microRNAs in NAFLD. Int J Mol Sci (2013) 0.95
Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid (2005) 0.95
Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J Hepatol (2012) 0.94
Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am J Gastroenterol (2013) 0.94
Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta (2005) 0.93
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis (2012) 0.93
Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments. Nutrition (2012) 0.93
Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease. PLoS One (2013) 0.92
Management of cholelithiasis in Italian children: a national multicenter study. World J Gastroenterol (2008) 0.91
Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol (2014) 0.91
Nonalcoholic fatty liver disease in children. J Am Coll Nutr (2008) 0.91
Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. Int J Endocrinol (2011) 0.90
Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. Hepat Mon (2013) 0.90
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease. PLoS One (2012) 0.89
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period. J Hepatol (2007) 0.89
Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J Pediatr Gastroenterol Nutr (2004) 0.89
Portal hypertension in children. Clin Res Hepatol Gastroenterol (2012) 0.88
The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol (2006) 0.88
Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats. Int J Mol Sci (2012) 0.88
A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis. J Gastroenterol (2006) 0.88
Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care (2010) 0.87
Liver fibrosis and therapeutic strategies: the goal for improving metabolism. Curr Drug Targets (2009) 0.87
Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease. Int J Mol Med (2012) 0.87
Glutathionylation of p65NF-kappaB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxidants. Int J Mol Med (2009) 0.87
Use of metformin in pediatric age. Pediatr Diabetes (2011) 0.86
Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health (2012) 0.86
Thyroid function tests in obese prepubertal children: correlations with insulin sensitivity and body fat distribution. Horm Res Paediatr (2012) 0.86
The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life. J Clin Endocrinol Metab (2013) 0.85
Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front Cell Infect Microbiol (2012) 0.85
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin. Genet Test (2007) 0.85
Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. Pediatr Nephrol (2009) 0.85
Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development. Hepatology (2011) 0.85
Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology (2009) 0.85
Intensive treatment and dietary fats in adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2008) 0.84
Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. Eur J Gastroenterol Hepatol (2012) 0.84
ADAR enzyme and miRNA story: a nucleotide that can make the difference. Int J Mol Sci (2013) 0.84
Blind and ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol (2003) 0.84
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology (2012) 0.84
I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology. Hepatology (2012) 0.83
Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr (2013) 0.83
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. Int J Mol Sci (2013) 0.83
Combined test for UGT1A1 -3279T-->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients. Genet Test (2006) 0.83
Liver fibrosis in paediatric liver diseases. Best Pract Res Clin Gastroenterol (2011) 0.82
Case management in children affected by non-alcoholic fatty liver disease. J Paediatr Child Health (2007) 0.82
Steatosis and fibrosis in paediatric liver transplant: insidious graft's enemies--a call for clinical studies and research. Pediatr Transplant (2010) 0.82
Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. Clin Endocrinol (Oxf) (2013) 0.81
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl. Vaccine (2011) 0.81
Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. J Hepatol (2010) 0.81
Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2007) 0.81
Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis. Hepatology (2010) 0.81